Literature DB >> 22248198

Protein oxidative stress and dyslipidemia in dialysis patients.

Andresa Marques de Mattos1, Larissa Vieira Marino, Paula Payão Ovidio, Alceu Afonso Jordão, Carla Cristina Almeida, Paula Garcia Chiarello.   

Abstract

Our aim was to investigate and determine the associations between oxidative stress (OS), dyslipidemia and inflammation in patients treated with continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis (HD) using observational cross-sectional study. Twenty patients in CAPD and 48 in HD for at least 8 weeks and aged ≥18 years were included in the study. Individuals with malignant or acute inflammatory disease were excluded. A control group of 17 healthy individuals was also recruited. The biochemical parameter evaluations were analyzed using colorimetric kits for albumin, serum glucose, total cholesterol (TC) and lipid fractions. To determine the inflammatory status, CRP, IL-6 and TNF-α were analyzed by automated chemiluminescence kits. Plasma advanced oxidation protein products (AOPP) were determined by spectrophotometry. Mean AOPP levels were significantly higher for the HD group compared to the control, and there was no difference in AOPP concentrations between the control and CAPD groups. Dialysis patients had levels of inflammatory parameters higher than controls, and showed a high prevalence of patients with dyslipidemia, especially in CAPD. In the HD group, AOPP was positively correlated with triglycerides (TG) and inversely associated with HDL. Also the HD group was observed to have negative associations between TNF-α and HDL, LDL and TC. In the CAPD group, CRP was inversely correlated with HDL. Hemodialysis patients had increased protein OS and associations of inflammation and dyslipidemia were also observed in these dialysis groups. A more detailed characterization of the relations between oxidative stress and other more traditional risk factors has therapeutic importance, since cardiovascular diseases are the leading cause of death among dialysis patients.
© 2011 The Authors. Therapeutic Apheresis and Dialysis © 2011 International Society for Apheresis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22248198     DOI: 10.1111/j.1744-9987.2011.01009.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  16 in total

1.  Ambient Fine Particulate Matter, Outdoor Temperature, and Risk of Metabolic Syndrome.

Authors:  Rachel S Wallwork; Elena Colicino; Jia Zhong; Itai Kloog; Brent A Coull; Pantel Vokonas; Joel D Schwartz; Andrea A Baccarelli
Journal:  Am J Epidemiol       Date:  2016-12-07       Impact factor: 4.897

Review 2.  Metabolic syndrome, aging and involvement of oxidative stress.

Authors:  Francesca Bonomini; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Aging Dis       Date:  2015-03-10       Impact factor: 6.745

3.  Different peptic ulcer bleeding risk in chronic kidney disease and end-stage renal disease patients receiving different dialysis.

Authors:  Kuang-Wei Huang; Hsin-Bang Leu; Jiing-Chyuan Luo; Wan-Leong Chan; Ming-Chih Hou; Han-Chieh Lin; Fa-Yauh Lee; Yi-Chun Kuan
Journal:  Dig Dis Sci       Date:  2013-12-08       Impact factor: 3.199

4.  Gastrointestinal bleeding in patients with renal failure under hemodialysis treatment: a single-center experience.

Authors:  Özgür Can; Gözde Koç; Sema Berk Ocak; Nursel Akbay; Emel Ahishali; Mustafa Canbakan; Gülizar Manga Şahin; Süheyla Apaydin
Journal:  Int Urol Nephrol       Date:  2017-01-25       Impact factor: 2.370

5.  Oxidative DNA damage and mortality in hemodialysis and peritoneal dialysis patients.

Authors:  Hong Xu; Makoto Watanabe; Abdul Rashid Qureshi; Olof Heimbürger; Peter Bárány; Björn Anderstam; Monica Eriksson; Peter Stenvinkel; Bengt Lindholm
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

Review 6.  The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: the great exploration.

Authors:  Rebecca Hutcheson; Petra Rocic
Journal:  Exp Diabetes Res       Date:  2012-07-09

7.  Malondialdehyde can predict survival in hemodialysis patients.

Authors:  Crina Claudia Rusu; Simona Racasan; Ina Maria Kacso; Diana Moldovan; Alina Potra; Ioan Mihai Patiu; Dan Vladutiu; Mirela Gherman Caprioara
Journal:  Clujul Med       Date:  2016-04-15

8.  Plasma protein-bound di-tyrosines as biomarkers of oxidative stress in end stage renal disease patients on maintenance haemodialysis.

Authors:  Graziano Colombo; Francesco Reggiani; David Cucchiari; Nicola M Portinaro; Daniela Giustarini; Ranieri Rossi; Maria Lisa Garavaglia; Nicola Saino; Aldo Milzani; Salvatore Badalamenti; Isabella Dalle-Donne
Journal:  BBA Clin       Date:  2017-01-05

Review 9.  Targeting cannabinoid signaling for peritoneal dialysis-induced oxidative stress and fibrosis.

Authors:  Chih-Yu Yang; Yat-Pang Chau; Ann Chen; Oscar Kuang-Sheng Lee; Der-Cherng Tarng; An-Hang Yang
Journal:  World J Nephrol       Date:  2017-05-06

10.  Serum Gamma-Glutamyltransferase Levels Predict Mortality in Patients With Peritoneal Dialysis.

Authors:  Woo-Yeong Park; Su-Hyun Kim; Young Ok Kim; Dong Chan Jin; Ho Chul Song; Euy Jin Choi; Yong Lim Kim; Yon Su Kim; Shin Wook Kang; Nam Ho Kim; Chul Woo Yang; Yong Kyun Kim
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.